Search - tctmd.com

Displaying 21 - 40 of 1143

Sort: Relevancy | Date

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

Presenter: Jeroen J. Bax, Ileana L. Pina, Ori Ben-Yehuda

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Presenter: Scott Berry, Stuart J. Pocock, Ajay J. Kirtane

October 30, 2016

Presentation TCT 2016

Mediation Analysis: A Method to Assign Attributable Risk

Presenter: Scott Berry, Stuart J. Pocock, Bjorn Redfors

October 30, 2016

Presentation TCT 2016

Surrogate Endpoints: Construction, Validation, and Trustiness

Presenter: Scott Berry, Stuart J. Pocock, William S. Weintraub

October 30, 2016

Presentation TCT 2016

Accounting for the Risk of Competing Events

Presenter: Scott Berry, Stuart J. Pocock, Peter Juni

October 30, 2016

Presentation TCT 2016

Analyzing Repeat Events

Presenter: Scott Berry, Stuart J. Pocock, Eugene H. Blackstone

October 30, 2016

Presentation TCT 2016

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Presenter: Scott Berry, Stuart J. Pocock, Jan G. P. Tijssen

October 30, 2016

Presentation TCT 2016

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Of Course! Renal Patients Are at the Highest Risk!

Presenter: Ian C. Gilchrist, James Nolan, Binita Shah

October 30, 2016

Presentation TCT 2016

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? No Way, Preserve Future Dialysis Access at All Costs!

Presenter: Ian C. Gilchrist, James Nolan, Michael S. Lee

October 30, 2016

Presentation TCT 2016

Case #1: Advanced MitraClip Steering: When Guide Torque and M-Knob Arent Enough

Presenter: James B. Hermiller Jr., Paul Sorajja, Scott Lim

October 30, 2016

Presentation TCT 2016

Personalized Medicine Where Are We in 2016?

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

Presentation TCT 2016

State-of-the-Art Lecture: Latest Advances in a Large Bore Vascular Closure Devices - What Does the Future Hold?

Presenter: Robert M. Bersin, Brian G. DeRubertis, Zvonimir Krajcer

October 30, 2016

Presentation TCT 2016

Anti-inflammatory Therapies for Atherosclerosis

Presenter: Robert A. Harrington, A. Michael Lincoff, Jean-Claude Tardif

October 30, 2016

Presentation TCT 2016

Treatment Strategies to Rescue Failing Endografts

Presenter: Robert M. Bersin, Brian G. DeRubertis, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

Advertisement

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Surgical and Transcatheter Aortic Valve Replacement for Patients With Heart Failure and High and Low Gradient Aortic Stenosis: Magnitude of Benefit and Prediction of Responders

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Risk Scores: Development, Validation, Utility, and Limitations (With Case Studies: Framingham, TIMI/GRACE, CHADS/HASBLED, DAPT, and Others)

Mediation Analysis: A Method to Assign Attributable Risk

Surrogate Endpoints: Construction, Validation, and Trustiness

Accounting for the Risk of Competing Events

Analyzing Repeat Events

Limitations of Composite Endpoints and Strategies for Hierarchical Testing

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? Of Course! Renal Patients Are at the Highest Risk!

Debate - Should Patients With Advanced Renal Disease Undergo PCI via Radial Access? No Way, Preserve Future Dialysis Access at All Costs!

Case #1: Advanced MitraClip Steering: When Guide Torque and M-Knob Arent Enough

Personalized Medicine Where Are We in 2016?

State-of-the-Art Lecture: Latest Advances in a Large Bore Vascular Closure Devices - What Does the Future Hold?

Anti-inflammatory Therapies for Atherosclerosis

Treatment Strategies to Rescue Failing Endografts

Heart Failure Advances (Ivabradine, ARNI, and More)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content